Picture of medmix AG logo

MEDX — medmix AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Medmix AG Says FY 2024 Revenue CHF 483.9M

Feb 26 (Reuters) - medmix AG MEDX.S:

MEDMIX AG - FY 2024 REVENUE AT CHF 483.9M, -0.6% (- 1.5% ORG. FX ADJUSTED.)

MEDMIX AG - 2025 TRANSITION YEAR WITH FLAT ORGANIC REVENUE GROWTH, ADJUSTED EBITDA MARGIN 18% TO 19%

MEDMIX AG - FY 2024 ADJUSTED. EBITDA MARGIN AT 19.1%,

MEDMIX AG - PROPOSES AN ORDINARY DIVIDEND OF CHF 0.50 PER SHARE FOR 2024

Source text: [ID:]

Further company coverage: MEDX.S

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on medmix AG

See all news